Cognex Corporation (CGNX)
NEUTRALFondamental
65
Prix
$59.70
Capitalisation boursière
$9.88B
Partie 1 · Ce que vaut l'entreprise
Vue d'ensemble
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks in the United States, Europe, Greater China, and internationally. Its machine vision products are used to automate the manufacture and distribution of discrete items, such as mobile phones, automotive components, and e-commerce packages, by locating, identifying, inspecting, and measuring them. The company offers VisionPro software, a suite of patented vision tools for traditional rule-based tools and deep learning-enabled tools for advanced programming; vision systems that combine smart cameras and software to perform a wide range of tasks, including part location, identification, measurement, assembly verification, and robotic guidance; OneVision, a cloud-based platform designed to transform how manufacturers build, train, and scale AI-powered vision applications; In-Sight product line of vision systems and sensors; QuickBuild, which allows customers to build vision applications with a graphical and flowchart-based programming interface; DataMan, an image-based barcode reader for fixed-mount and handheld models, as well as barcode verifiers; and vision accessories, such as industrial cameras, lenses, lighting, vision controllers, frame grabbers, and I/O cards. It sells its products to the automotive, logistics, packaging, consumer electronics, medical-related, semiconductor, and consumer products industries. The company was incorporated in 1981 and is headquartered in Natick, Massachusetts.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Bilan & Liquidités
Chiffre d'affaires
$1.09B
12 derniers mois (au 05/07/2026)
Résultat net
$175M
12 derniers mois (au 05/07/2026)
Flux de trésorerie libre
$237M
Capitaux propres totaux
$1.49B
Passif total
$525M
Ratio de liquidité général
3.93
Couverture des intérêts
-
Dette/EBITDA
0.27
Bénéfice par action
Chiffre d'affaires & Résultat net
Flux de trésorerie libre
Décomposition du résultat
État historique
Marges dans le temps
La dette dans le temps
Le poids de la dette
Grille de la croissance
Croissance — Chiffre d'affaires
Estimation de la juste valeur
Juste valeur
$42.25
Prix actuel
$59.70
Marge de sécurité
-41.3%
Fourchette de juste valeur
$27.46 - $57.04
Méthodes d'estimation
Indicateurs de valorisation
Ratio P/E
56.29
ROE
7.7%
Ratio P/B
6.04
P/FCF
36.71
Marge brute
68.9%
ROIC
9.6%
Radar de rentabilité
Value Creation (Economic Moat)
ROIC
9.6%
WACC
12.6%
ROIC − WACC
-3.0 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
Critères d'analyse fondamentale
Réussi (18)
- EPS shows upward trend
- Price CAGR 6.65%
- ROIC 9.6%
- Gross Margin 68.9%
- Debt/Equity ratio
- Operating Margin 21.9%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 8.0%
- Analyst Consensus 75% Buy
- Earnings Surprise avg 17.5%
- Earnings Quality (OCF/NI) 1.58
- Share Dilution -1.7%
- Net Margin Trend 16.1% vs 13.1%
- Piotroski F-Score 7/9
Échoué (7)
- EPS CAGR 0.18%
- P/FCF 36.71
- P/B Ratio 6.04
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Revenue Growth 5Y 4.2%
Indisponible (3)
- Dividend Payout NaN%
- Interest Coverage
- PEG Ratio (need PE > 0 and growth > 0)
Score F de Piotroski
Santé financière solide
Qualité des bénéfices
Qualité élevée : bénéfices soutenus par la trésorerie
Dilution du capital
Rachat d'actions. Favorable aux actionnaires
Gouvernance
Équipe dirigeante
| Nom | Titre | Âge |
|---|---|---|
| Mr. Matthew Moschner | President, CEO & Director | 38 |
| Mr. Dennis S. Fehr | Senior VP of Finance & CFO | 44 |
| Mr. Carl W. Gerst III | Executive Vice President of Global Sales & Products | 57 |
| Ms. Sheila M. DiPalma CPA | Executive VP of Employee Services & Chief Culture Officer | 58 |
| Dr. Robert J. Shillman Ph.D. | Founder, Chairman Emeritus & Adviser | 78 |
| Mr. Mike Bowdoin | Vice President of Operations | - |
| Ms. Laura Ann MacDonald | VP of Finance, Corporate Controller & Interim Principal Acc Officer | 56 |
| Ms. Greer Aviv | Head of Investor Relations | - |
| Mr. Mark T. Fennell | VP, Chief Legal Officer & Corporate Secretary | - |
| Ms. Robin Pratt | Corporate Communications Contractor | - |
Risque d'audit
7
Risque du conseil
3
Risque de rémunération
6
Risque droits des actionnaires
6
Partie 2 · Le prix et le moment d'entrer
Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.
Latest News
Recent headlines for CGNX, sourced from Markets Gazette.
- 3/9/2026NEUTRALAssessing Cognex: Insights From 10 Financial Analysts
Cognex Corporation (CGNX) is under review by financial analysts, with recent actions showing mixed sentiment. In March 2022, Goldman Sachs maintained a 'Sell' rating. Prior to that, in February 2022, Morgan Stanley maintained an 'Equal-Weight' rating, and JP Morgan upgraded the stock from 'Underweight' to 'Neutral'. This divergence in analyst opinions suggests a lack of clear consensus on the company's future performance, making it a neutral signal for investors at this time.
- 2/24/2026POSITIVE$100 Invested In Cognex 20 Years Ago Would Be Worth This Much Today
A recent analysis, hinted at by a provocative headline, suggests that a hypothetical $100 investment in Cognex Corporation two decades ago would today command a substantially higher value. While the precise figures remain undisclosed in the snippet, the implication points to Cognex's remarkable long-term growth trajectory and its capacity to generate significant returns for early investors. This historical performance underscores the company's resilience and innovation in the machine vision industry, positioning it as a compelling case study for patient, growth-oriented portfolios. Investors often look to such examples as indicators of a company's fundamental strength and future potential, even if past performance is not a guarantee of future results.
- 2/22/2026NEGATIVEIs Cognex Stock a Buy or Sell After a Director Dumped Shares Worth $128,000?
A cautionary signal has emerged from Cognex Corporation, a global leader in machine vision systems and industrial automation. A company director recently sold shares worth $128,000. While the amount itself is not staggering, the transaction is noteworthy given the stock's strong performance over the past year. Insider sales are often interpreted by the market as a potential indicator that a stock's valuation may have peaked or that future challenges lie ahead. Investors might question the management's confidence in near-term growth prospects. This event, while not a definitive red flag, warrants a closer look at the company's fundamentals and encourages monitoring for any further sales by key executives, which could reinforce a bearish signal.
via Markets Gazette